Harpoon Therapeutics (HARP) Stock Forecast & Price Target

Notice: This company has been marked as potentially delisted and may not be actively trading.

Stock Analysis Analyst Forecasts Earnings Headlines Insider Trades Ownership Sustainability Trends

Harpoon Therapeutics - Analysts' Recommendations and Stock Price Forecast (2024)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Rating

Hold
Based on 6 Analyst Ratings

Based on 6 Wall Street analysts who have issued ratings for Harpoon Therapeutics in the last 12 months, the stock has a consensus rating of "Hold." Out of the 6 analysts, 4 have given a hold rating, and 2 have given a buy rating for HARP.

Consensus Price Target

$27.25
18.43% Upside

High Forecast	$40.00
Average Forecast	$27.25
Low Forecast	$23.00

According to the 6 analysts' twelve-month price targets for Harpoon Therapeutics, the average price target is $27.25. The highest price target for HARP is $40.00, while the lowest price target for HARP is $23.00. The average price target represents a forecasted upside of 18.43% from the current price of $23.01.

Type	Current Forecast 9/8/23 to 9/7/24	1 Month Ago 8/9/23 to 8/8/24	3 Months Ago 6/10/23 to 6/9/24	1 Year Ago 9/8/22 to 9/8/23
Consensus Rating	Hold	Hold	Hold	Moderate Buy
Strong Buy	0 Strong Buy rating(s)	0 Strong Buy rating(s)	0 Strong Buy rating(s)	0 Strong Buy rating(s)
Buy	2 Buy rating(s)	2 Buy rating(s)	2 Buy rating(s)	3 Buy rating(s)
Hold	4 Hold rating(s)	4 Hold rating(s)	4 Hold rating(s)	2 Hold rating(s)
Sell	0 Sell rating(s)	0 Sell rating(s)	0 Sell rating(s)	0 Sell rating(s)
Consensus Price Target	$27.25	$27.25	$27.25	$40.00
Forecasted Upside	18.43% Upside	70.18% Upside	70.18% Upside	401.38% Upside

Get Harpoon Therapeutics Upgrade and Downgrade Alerts

Sign-up to receive the latest news and ratings for HARP and its competitors with MarketBeat's FREE daily newsletter.

Ad Porter & Company

Trump’s weapon lurks in abandoned America

Unemployment is sky-high, wages are at record lows. Addiction has overwhelmed these once thriving coal towns. Hopelessness abounds. And looking in, the future here looks bleak for these forgotten souls. But in a strange twist of fate, something miraculous is taking place…

Go here now to watch my new documentary

HARP Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.

HARP Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.

Harpoon Therapeutics Stock vs. The Competition

Type	Harpoon Therapeutics	Medical Companies	S&P 500
Consensus Rating Score	2.33	2.77	2.51
Consensus Rating	Hold	Moderate Buy	Moderate Buy
Predicted Upside	18.43% Upside	1,207.57% Upside	11.36% Upside
News Sentiment Rating	Positive News	Positive News	Positive News

Recent Analyst Forecasts and Stock Ratings

Rating

Upside/Downside

Action

Time Frame

Start Date

End Date

Show

Export to Excel

Date	Brokerage	Analyst Name	Action	Rating	Price Target	Upside/Downside on Report Date
3/26/2024	Oppenheimer 3 of 5 stars		Reiterated Rating	Outperform ➝ Outperform
2/26/2024	Citigroup 3 of 5 stars		Reiterated Rating	Buy ➝ Neutral	$13.00 ➝ $23.00	+0.26%
1/16/2024	TD Cowen 4 of 5 stars		Reiterated Rating	Outperform ➝ Market Perform
1/8/2024	Leerink Partnrs Subscribe to MarketBeat All Access for the recommendation accuracy rating	J. Chang Subscribe to MarketBeat All Access for the recommendation accuracy rating	Downgrade	Outperform ➝ Market Perform
1/8/2024	HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating	S. Ramakanth Subscribe to MarketBeat All Access for the recommendation accuracy rating	Downgrade	Buy ➝ Neutral	$12.00 ➝ $23.00	+2.63%
9/14/2023	Canaccord Genuity Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		Lower Target	Buy ➝ Buy	$80.00 ➝ $40.00	+649.06%
5/15/2023	500.com Subscribe to MarketBeat All Access for the recommendation accuracy rating		Reiterated Rating	Reiterates
12/14/2022	Truist Financial Subscribe to MarketBeat All Access for the recommendation accuracy rating		Downgrade	Buy ➝ Hold	$20.00	+124.69%
11/17/2022	Robert W. Baird Subscribe to MarketBeat All Access for the recommendation accuracy rating		Lower Target		$15.00	+105.48%
11/15/2022	Leerink Partners Subscribe to MarketBeat All Access for the recommendation accuracy rating		Lower Target	Outperform	$100.00 ➝ $40.00	+406.20%

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Saturday at 04:56 PM ET.

HARP Forecast - Frequently Asked Questions

What is Harpoon Therapeutics' forecast for 2024?: According to the research reports of 6 Wall Street equities research analysts, the average twelve-month stock price forecast for Harpoon Therapeutics is $27.25, with a high forecast of $40.00 and a low forecast of $23.00.
Should I buy or sell Harpoon Therapeutics stock right now?: 6 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Harpoon Therapeutics in the last year. There are currently 4 hold ratings and 2 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "hold" HARP shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in HARP, but not buy additional shares or sell existing shares.
Does Harpoon Therapeutics's stock price have much upside?: According to analysts, Harpoon Therapeutics's stock has a predicted upside of 70.18% based on their 12-month stock forecasts.
Do Wall Street analysts like Harpoon Therapeutics more than its competitors?: Analysts like Harpoon Therapeutics less than other "medical" companies. The consensus rating for Harpoon Therapeutics is Hold while the average consensus rating for "medical" companies is Moderate Buy. Learn more on how HARP compares to other companies.